Lonza EasyDiff supplements for bone marrow CD34+

Friday, 22 July, 2011 | Supplied by: Capsugel Australia Pty Ltd

Lonza EasyDiff supplements for bone marrow CD34+

Primary human bone marrow hematopoietic progenitors are multipotent cells that can differentiate into several lineages. EasyDiff supplements allow differentiation of CD34+ cells into three different hematopoietic lineages (myeloid, erythroid and megakaryocytic) in 96-well plates.

Users simply add the appropriate volume of media (LGM-3 or IMDM) to dilute the supplement and mix with CD34+ cells in media. Once plated into 96-well plates differentiation will be complete in 10-12 days.

There is no need for methylcellulose or any substrate. Users can verify differentiation via quantification of the expression of lineage-specific markers.

The supplements are suitable for both drug discovery and toxicology research.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

AdipoGen Life Sciences GLP-1, GIP and GCG receptor agonists

AdipoGen's range of GLP-1, GIP and GCG receptor agonists includes Liraglutide, Retatrutide,...

Integrated DNA Technologies xGen Hybridization and Wash v3 Kit

Integrated DNA Technologies (IDT) has unveiled its xGen Hybridization and Wash v3 Kit — a...

Cytek Tonbo Reagents

Cytek Tonbo Reagents are designed to enable high-quality research without breaking the budget....


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd